Skip to Content

R717 (Lamotrigine Extended-Release 25 mg)

Pill with imprint R717 is Yellow, Round and has been identified as Lamotrigine Extended-Release 25 mg. It is supplied by Dr.Reddy's Laboratories Limited.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; borderline personality disorder; epilepsy; seizure prevention (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R717

Lamotrigine Extended-Release

Imprint:
R717
Strength:
25 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr.Reddy's Laboratories Limited
National Drug Code (NDC):
55111-0717

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide